This volume in the Diagnostic Pathology series is an ideal point-of-care resource for practitioners at all levels of experience and training. Covering the full range of solid organ transplantation (SOT) of the kidney, liver, heart, lung, pancreas, intestine, and more, it provides a current understanding of transplant immunology and pathology to help ensure accurate diagnosis for optimal clinical management. Richly illustrated and easy to use, Diagnostic Pathology: Transplant Pathology, third edition, is a visually stunning, one-stop reference for practicing pathologists, transplant practitioners, and students of organ transplantation.
1. Chapter 6: Introduction to Xenotransplantation - p. 29 2. Chapter 7: Graft-vs.-Host Disease in Solid Organ Transplantation - p. 31 3. Section 2: HLA Testing - p. 33 4. Chapter 8: Human Leukocyte Antigen System - p. 33 5. Chapter 9: Histocompatibility Testing - p. 37 6. Chapter 10: Transplantation and HLA - p. 39 7. Chapter 11: ABO Blood Group Antigens and Transplantation - p. 43 8. Chapter 12: Apheresis and Transplantation - p. 45 9. Chapter 13: HLA and Transfusion - p. 47 10. Section 3: Immunosuppressive Drugs - p. 49 11. Chapter 14: Mechanism of Action of Immunosuppressive Drugs - p. 49 12. Chapter 15: Therapeutic Drug Monitoring in Transplant Patients - p. 53 13. Chapter 16: History of Immunosuppression Drugs in Transplantation - p. 57 14. Section 4: Kidney Transplantation - p. 59 15. Chapter 17: History of Kidney Transplantation - p. 59 16. Chapter 18: Pathologic Classification of Renal Allograft Diseases - p. 63 17. Chapter 19: Examination of End-Stage Kidney - p. 65 18. Chapter 20: Evaluation of End-Stage Kidney - p. 71 19. Chapter 21: Evaluation of Allograft Kidney - p. 77 20. Chapter 22: Evaluation of Donor Kidney - p. 83 21. Chapter 23: Evaluation of Transplant Nephrectomy - p. 89 22. Chapter 24: Evaluation of Fibrosis - p. 93 23. Chapter 25: Protocol Biopsies - p. 97 24. Chapter 26: Accommodation - p. 101 25. Chapter 27: Tolerance - p. 103 26. Surgical Complications - p. 107 27. Chapter 28: Acute Allograft Ischemia - p. 107 28. Chapter 29: Size Mismatch Allograft Injury - p. 111 29. Chapter 30: Urine Leak - p. 113 30. Chapter 31: Lymphocele - p. 114 31. Chapter 32: Multinucleated Endotheliopathy - p. 115 32. Chapter 33: Transplant Renal Artery Stenosis - p. 119 33. Chapter 34: Transplant Renal Artery or Vein Thrombosis - p. 121 34. Chapter 35: Kidney Xenografts - p. 123 35. Allograft Rejection - p. 127 36. Chapter 36: Hyperacute Rejection - p. 127 37. Chapter 37: Acute T-Cell-Mediated Rejection - p. 131 38. Chapter 38: Chronic T-Cell-Mediated Rejection - p. 141 39. Chapter 39: Acute Antibody-Mediated Rejection - p. 145 40. Chapter 40: Chronic Antibody-Mediated Rejection - p. 153 41. Chapter 41: Transcript Analysis of Renal Transplant Biopsies - p. 165 42. Recurrent and De Novo Diseases - p. 169 43. Chapter 42: Diseases That Recur in Allografts - p. 169 44. Chapter 43: De Novo Focal Segmental Glomerulosclerosis - p. 175 45. Chapter 44: De Novo Membranous Nephropathy - p. 177 46. Chapter 45: Anti-GBM Disease in Alport Syndrome - p. 181 47. Chapter 46: Chimerism Transition Syndrome - p. 183 48. Chapter 47: Late Posttransplant Histology - p. 185 49. Kidney Pathology of Recipients of Other Transplants - p. 187 50. Chapter 48: Kidney Diseases in Nonrenal Transplant Recipients - p. 187 51. Chapter 49: Graft-vs.-Host Glomerulopathies - p. 191 52. Drug Toxicities - p. 193 53. Chapter 50: Calcineurin Inhibitor Toxicity - p. 193 54. Chapter 51: mTOR Inhibitor Toxicity - p. 199 55. Infections - p. 201 56. Chapter 52: Acute Pyelonephritis - p. 201 57. Chapter 53: Polyomavirus Nephritis - p. 209 58. Chapter 54: Adenovirus Infection - p. 217 59. Chapter 55: Cytomegalovirus Infection - p. 219 60. Chapter 56: Mucormycosis - p. 221 61. Chapter 57: Histoplasmosis - p. 223 62. Chapter 58: Candidiasis - p. 224 63. Chapter 59: Cryptococcosis - p. 225 64. Chapter 60: Aspergillosis - p. 226 65. Chapter 61: Coccidioidomycosis - p. 227 66. Chapter 62: Paracoccidioidomycosis - p. 228 67. Chapter 63: Microsporidiosis - p. 229 68. Chapter 64: Tuberculosis - p. 231 69. Chapter 65: Malakoplakia - p. 233 70. Chapter 66: Nocardiosis - p. 237 71. Section 5: Liver Transplantation - p. 239 72. Chapter 67: Pathologic Classification of Liver Allograft Diseases - p. 239 73. Chapter 68: Gross Evaluation of Native Liver - p. 243 74. Chapter 69: Evaluation of Failed Liver Allograft - p. 247 75. Chapter 70: Evaluation of Donor Liver - p. 249 76. Chapter 71: History of Liver Transplantation - p. 253 77. Posttransplant Surgical Complications - p. 255 78. Chapter 72: Preservation Injury - p. 255 79. Chapter 73: Hepatic Artery Thrombosis - p. 257 80. Chapter 74: Portal Vein Thrombosis - p. 259 81. Chapter 75: Bile Duct Stricture, Leak, Sludge, Biloma - p. 261 82. Chapter 76: Hepatic Venous Outflow Obstruction - p. 263 83. Chapter 77: Small-for-Size (Hyperperfusion) Syndrome - p. 267 84. Allograft Rejection - p. 269 85. Chapter 78: T-Cell-Mediated Rejection, Liver - p. 269 86. Chapter 79: Antibody-Mediated Rejection, Liver - p. 273 87. Chapter 80: Chronic (Ductopenic) Rejection - p. 277 88. Recurrent Diseases in Liver Allograft - p. 279 89. Chapter 81: Recurrent Hepatitis B Virus - p. 279 90. Chapter 82: Recurrent Hepatitis C Virus - p. 281 91. Chapter 83: Fibrosing Cholestatic HBV or HCV Hepatitis - p. 285 92. Chapter 84: Recurrent Autoimmune Hepatitis - p. 287 93. Chapter 85: Recurrent Primary Biliary Cholangitis - p. 289 94. Chapter 86: Recurrent Primary Sclerosing Cholangitis - p. 291 95. Chapter 87: Recurrent Fatty Liver Disease - p. 293 96. Infections - p. 295 97. Chapter 88: Cytomegalovirus - p. 295 98. Chapter 89: Herpes Simplex Virus - p. 297 99. Chapter 90: Adenovirus, Liver - p. 299 100. Chapter 91: Hepatitis E Virus - p. 301 101. Chapter 92: Epstein-Barr Virus, Liver - p. 303 102. Chapter 93: Fungal Infections, Liver - p. 307 103. Late-Graft Dysfunction - p. 309 104. Chapter 94: Plasma Cell-Rich Rejection - p. 309 105. Chapter 95: Graft-vs.-Host Disease, Liver - p. 311 106. Section 6: Heart Transplantation - p. 313 107. Chapter 96: Pathologic Classification of Cardiac Allograft Diseases - p. 313 108. Chapter 97: Evaluation of Failed Native and Transplanted Heart - p. 317 109. Chapter 98: History of Heart Transplantation - p. 319 110. Evaluation of Explanted Heart - p. 321 111. Chapter 99: Ischemic Heart Disease - p. 321 112. Chapter 100: Dilated Cardiomyopathy - p. 325 113. Chapter 101: Hypertrophic Cardiomyopathy - p. 329 114. Chapter 102: Congenital Heart Disease - p. 333 115. Chapter 103: Sarcoidosis, Heart - p. 337 116. Chapter 104: Arrhythmogenic Cardiomyopathy - p. 339 117. Chapter 105: Other Causes of End-Stage Heart Disease - p. 343 118. Allograft Rejection - p. 349 119. Chapter 106: Acute Cellular Rejection, Heart - p. 349 120. Chapter 107: Antibody-Mediated Rejection, Heart - p. 353 121. Chapter 108: Chronic Allograft Vasculopathy, Heart - p. 355 122. Noninfectious Lesions - p. 357 123. Chapter 109: Quilty Lesions - p. 357 124. Chapter 110: Site of Previous Biopsy - p. 359 125. Infections - p. 361 126. Chapter 111: Myocarditis - p. 361 127. Section 7: Lung Transplantation - p. 367 128. Chapter 112: Pathologic Classification of Lung Allograft Diseases - p. 367 129. Chapter 113: Examination of Native and Transplanted Lungs - p. 371 130. Chapter 114: History of Lung Transplantation - p. 373 131. Evaluation of Failed Native Lung - p. 375 132. Chapter 115: Emphysema - p. 375 133. Chapter 116: Cystic Fibrosis - p. 377 134. Chapter 117: Idiopathic Pulmonary Fibrosis - p. 379 135. Chapter 118: Connective Tissue Disease-Associated Interstitial Lung Disease - p. 381 136. Chapter 119: Sarcoidosis, Lung - p. 383 137. Chapter 120: Pulmonary Arterial Hypertension - p. 385 138. Chapter 121: Other Causes of End-Stage Lung Disease - p. 387 139. Surgical Complications - p. 391 140. Chapter 122: Surgical Aspects and Complications, Lung - p. 391 141. Allograft Rejection - p. 393 142. Chapter 123: Pathologic Classification of Rejection - p. 393 143. Chapter 124: Antibody-Mediated Rejection, Lung - p. 395 144. Chapter 125: Acute Cellular Rejection, Grade A - p. 397 145. Chapter 126: Acute Cellular Rejection, Grade B - p. 399 146. Chapter 127: Chronic Allograft Dysfunction, Lung - p. 401 147. Noninfectious Lesions - p. 403 148. Chapter 128: Organizing Pneumonia - p. 403 149. Chapter 129: Microaspiration - p. 405 150. Infections - p. 407 151. Chapter 130: Bacterial Infections - p. 407 152. Chapter 131: Viral Infections - p. 409 153. Chapter 132: Fungal Infections, Lung - p. 413 154. Section 8: Intestinal Transplantation - p. 417 155. Chapter 133: Pathologic Classification of Intestinal Allograft Diseases - p. 417 156. Chapter 134: Indications and Evaluation of Explant - p. 421 157. Chapter 135: Reperfusion Injury - p. 425 158. Chapter 136: History of Intestinal and Multivisceral Transplantation - p. 429 159. Allograft Rejection/Immunological Injury - p. 431 160. Chapter 137: Acute Antibody-Mediated Rejection, Intestine - p. 431 161. Chapter 138: Acute Cellular Rejection, Intestine - p. 435 162. Chapter 139: Chronic Rejection, Intestine - p. 443 163. Chapter 140: Stomach Rejection - p. 447 164. Chapter 141: Colon Rejection - p. 451 165. Chapter 142: Graft-vs.-Host Disease, Intestine - p. 455 166. Infections - p. 459 167. Chapter 143: Bacterial and Fungal Infections - p. 459 168. Chapter 144: Adenovirus, Intestine - p. 463 169. Chapter 145: Rotavirus, Cytomegalovirus, and Herpes Simplex Virus - p. 467 170. Chapter 146: Epstein-Barr Virus, Intestine - p. 471 171. Section 9: Pancreas Transplantation - p. 477 172. Chapter 147: Pathologic Classification of Pancreas Allograft Diseases - p. 477 173. Chapter 148: Clinical Considerations in Pancreas Transplant Evaluation - p. 481 174. Chapter 149: History of Pancreas Transplantation - p. 487 175. Chapter 150: History of Islet Transplantation - p. 489 176. Surgical Complications - p. 491 177. Chapter 151: Surgical Aspects and Complications, Pancreas - p. 491 178. Allograft Rejection - p. 499 179. Chapter 152: T-Cell-Mediated Rejection, Pancreas - p. 499 180. Chapter 153: Antibody-Mediated Rejection, Pancreas - p. 505 181. Chapter 154: Pancreas Allograft Fibrosis/Graft Sclerosis - p. 509 182. Graft Dysfunction - p. 513 183. Chapter 155: Recurrent Diabetes Mellitus - p. 513 184. Chapter 156: Islet Cell Toxicity and Islet Amyloid Deposition - p. 517 185. Infections - p. 519 186. Chapter 157: Intraabdominal and Opportunistic Infections - p. 519 187. Section 10: Vascularized Composite Allotransplantation - p. 525 188. Chapter 158: History of Vascularized Composite Allotransplantation - p. 525 189. Chapter 159: Complications of Vascularized Composite Allotransplantation - p. 529 190. Allograft Rejection - p. 531 191. Chapter 160: Acute T-Cell- and Antibody-Mediated Rejection - p. 531 192. Chapter 161: Chronic Rejection - p. 539 193. Section 11: Posttransplant Neoplastic Disorders - p. 541 194. Chapter 162: Posttransplant Lymphoproliferative Diseases - p. 541 195. INDEX - p. 553
This volume in the Diagnostic Pathology series is an ideal point-of-care resource for practitioners at all levels of experience and training. Covering the full range of solid organ transplantation (SOT) of the kidney, liver, heart, lung, pancreas, intestine, and more, it provides a current understanding of transplant immunology and pathology to help ensure accurate diagnosis for optimal clinical management. Richly illustrated and easy to use, Diagnostic Pathology: Transplant Pathology, third edition, is a visually stunning, one-stop reference for practicing pathologists, transplant practitioners, and students of organ transplantation.
1. Chapter 6: Introduction to Xenotransplantation - p. 29 2. Chapter 7: Graft-vs.-Host Disease in Solid Organ Transplantation - p. 31 3. Section 2: HLA Testing - p. 33 4. Chapter 8: Human Leukocyte Antigen System - p. 33 5. Chapter 9: Histocompatibility Testing - p. 37 6. Chapter 10: Transplantation and HLA - p. 39 7. Chapter 11: ABO Blood Group Antigens and Transplantation - p. 43 8. Chapter 12: Apheresis and Transplantation - p. 45 9. Chapter 13: HLA and Transfusion - p. 47 10. Section 3: Immunosuppressive Drugs - p. 49 11. Chapter 14: Mechanism of Action of Immunosuppressive Drugs - p. 49 12. Chapter 15: Therapeutic Drug Monitoring in Transplant Patients - p. 53 13. Chapter 16: History of Immunosuppression Drugs in Transplantation - p. 57 14. Section 4: Kidney Transplantation - p. 59 15. Chapter 17: History of Kidney Transplantation - p. 59 16. Chapter 18: Pathologic Classification of Renal Allograft Diseases - p. 63 17. Chapter 19: Examination of End-Stage Kidney - p. 65 18. Chapter 20: Evaluation of End-Stage Kidney - p. 71 19. Chapter 21: Evaluation of Allograft Kidney - p. 77 20. Chapter 22: Evaluation of Donor Kidney - p. 83 21. Chapter 23: Evaluation of Transplant Nephrectomy - p. 89 22. Chapter 24: Evaluation of Fibrosis - p. 93 23. Chapter 25: Protocol Biopsies - p. 97 24. Chapter 26: Accommodation - p. 101 25. Chapter 27: Tolerance - p. 103 26. Surgical Complications - p. 107 27. Chapter 28: Acute Allograft Ischemia - p. 107 28. Chapter 29: Size Mismatch Allograft Injury - p. 111 29. Chapter 30: Urine Leak - p. 113 30. Chapter 31: Lymphocele - p. 114 31. Chapter 32: Multinucleated Endotheliopathy - p. 115 32. Chapter 33: Transplant Renal Artery Stenosis - p. 119 33. Chapter 34: Transplant Renal Artery or Vein Thrombosis - p. 121 34. Chapter 35: Kidney Xenografts - p. 123 35. Allograft Rejection - p. 127 36. Chapter 36: Hyperacute Rejection - p. 127 37. Chapter 37: Acute T-Cell-Mediated Rejection - p. 131 38. Chapter 38: Chronic T-Cell-Mediated Rejection - p. 141 39. Chapter 39: Acute Antibody-Mediated Rejection - p. 145 40. Chapter 40: Chronic Antibody-Mediated Rejection - p. 153 41. Chapter 41: Transcript Analysis of Renal Transplant Biopsies - p. 165 42. Recurrent and De Novo Diseases - p. 169 43. Chapter 42: Diseases That Recur in Allografts - p. 169 44. Chapter 43: De Novo Focal Segmental Glomerulosclerosis - p. 175 45. Chapter 44: De Novo Membranous Nephropathy - p. 177 46. Chapter 45: Anti-GBM Disease in Alport Syndrome - p. 181 47. Chapter 46: Chimerism Transition Syndrome - p. 183 48. Chapter 47: Late Posttransplant Histology - p. 185 49. Kidney Pathology of Recipients of Other Transplants - p. 187 50. Chapter 48: Kidney Diseases in Nonrenal Transplant Recipients - p. 187 51. Chapter 49: Graft-vs.-Host Glomerulopathies - p. 191 52. Drug Toxicities - p. 193 53. Chapter 50: Calcineurin Inhibitor Toxicity - p. 193 54. Chapter 51: mTOR Inhibitor Toxicity - p. 199 55. Infections - p. 201 56. Chapter 52: Acute Pyelonephritis - p. 201 57. Chapter 53: Polyomavirus Nephritis - p. 209 58. Chapter 54: Adenovirus Infection - p. 217 59. Chapter 55: Cytomegalovirus Infection - p. 219 60. Chapter 56: Mucormycosis - p. 221 61. Chapter 57: Histoplasmosis - p. 223 62. Chapter 58: Candidiasis - p. 224 63. Chapter 59: Cryptococcosis - p. 225 64. Chapter 60: Aspergillosis - p. 226 65. Chapter 61: Coccidioidomycosis - p. 227 66. Chapter 62: Paracoccidioidomycosis - p. 228 67. Chapter 63: Microsporidiosis - p. 229 68. Chapter 64: Tuberculosis - p. 231 69. Chapter 65: Malakoplakia - p. 233 70. Chapter 66: Nocardiosis - p. 237 71. Section 5: Liver Transplantation - p. 239 72. Chapter 67: Pathologic Classification of Liver Allograft Diseases - p. 239 73. Chapter 68: Gross Evaluation of Native Liver - p. 243 74. Chapter 69: Evaluation of Failed Liver Allograft - p. 247 75. Chapter 70: Evaluation of Donor Liver - p. 249 76. Chapter 71: History of Liver Transplantation - p. 253 77. Posttransplant Surgical Complications - p. 255 78. Chapter 72: Preservation Injury - p. 255 79. Chapter 73: Hepatic Artery Thrombosis - p. 257 80. Chapter 74: Portal Vein Thrombosis - p. 259 81. Chapter 75: Bile Duct Stricture, Leak, Sludge, Biloma - p. 261 82. Chapter 76: Hepatic Venous Outflow Obstruction - p. 263 83. Chapter 77: Small-for-Size (Hyperperfusion) Syndrome - p. 267 84. Allograft Rejection - p. 269 85. Chapter 78: T-Cell-Mediated Rejection, Liver - p. 269 86. Chapter 79: Antibody-Mediated Rejection, Liver - p. 273 87. Chapter 80: Chronic (Ductopenic) Rejection - p. 277 88. Recurrent Diseases in Liver Allograft - p. 279 89. Chapter 81: Recurrent Hepatitis B Virus - p. 279 90. Chapter 82: Recurrent Hepatitis C Virus - p. 281 91. Chapter 83: Fibrosing Cholestatic HBV or HCV Hepatitis - p. 285 92. Chapter 84: Recurrent Autoimmune Hepatitis - p. 287 93. Chapter 85: Recurrent Primary Biliary Cholangitis - p. 289 94. Chapter 86: Recurrent Primary Sclerosing Cholangitis - p. 291 95. Chapter 87: Recurrent Fatty Liver Disease - p. 293 96. Infections - p. 295 97. Chapter 88: Cytomegalovirus - p. 295 98. Chapter 89: Herpes Simplex Virus - p. 297 99. Chapter 90: Adenovirus, Liver - p. 299 100. Chapter 91: Hepatitis E Virus - p. 301 101. Chapter 92: Epstein-Barr Virus, Liver - p. 303 102. Chapter 93: Fungal Infections, Liver - p. 307 103. Late-Graft Dysfunction - p. 309 104. Chapter 94: Plasma Cell-Rich Rejection - p. 309 105. Chapter 95: Graft-vs.-Host Disease, Liver - p. 311 106. Section 6: Heart Transplantation - p. 313 107. Chapter 96: Pathologic Classification of Cardiac Allograft Diseases - p. 313 108. Chapter 97: Evaluation of Failed Native and Transplanted Heart - p. 317 109. Chapter 98: History of Heart Transplantation - p. 319 110. Evaluation of Explanted Heart - p. 321 111. Chapter 99: Ischemic Heart Disease - p. 321 112. Chapter 100: Dilated Cardiomyopathy - p. 325 113. Chapter 101: Hypertrophic Cardiomyopathy - p. 329 114. Chapter 102: Congenital Heart Disease - p. 333 115. Chapter 103: Sarcoidosis, Heart - p. 337 116. Chapter 104: Arrhythmogenic Cardiomyopathy - p. 339 117. Chapter 105: Other Causes of End-Stage Heart Disease - p. 343 118. Allograft Rejection - p. 349 119. Chapter 106: Acute Cellular Rejection, Heart - p. 349 120. Chapter 107: Antibody-Mediated Rejection, Heart - p. 353 121. Chapter 108: Chronic Allograft Vasculopathy, Heart - p. 355 122. Noninfectious Lesions - p. 357 123. Chapter 109: Quilty Lesions - p. 357 124. Chapter 110: Site of Previous Biopsy - p. 359 125. Infections - p. 361 126. Chapter 111: Myocarditis - p. 361 127. Section 7: Lung Transplantation - p. 367 128. Chapter 112: Pathologic Classification of Lung Allograft Diseases - p. 367 129. Chapter 113: Examination of Native and Transplanted Lungs - p. 371 130. Chapter 114: History of Lung Transplantation - p. 373 131. Evaluation of Failed Native Lung - p. 375 132. Chapter 115: Emphysema - p. 375 133. Chapter 116: Cystic Fibrosis - p. 377 134. Chapter 117: Idiopathic Pulmonary Fibrosis - p. 379 135. Chapter 118: Connective Tissue Disease-Associated Interstitial Lung Disease - p. 381 136. Chapter 119: Sarcoidosis, Lung - p. 383 137. Chapter 120: Pulmonary Arterial Hypertension - p. 385 138. Chapter 121: Other Causes of End-Stage Lung Disease - p. 387 139. Surgical Complications - p. 391 140. Chapter 122: Surgical Aspects and Complications, Lung - p. 391 141. Allograft Rejection - p. 393 142. Chapter 123: Pathologic Classification of Rejection - p. 393 143. Chapter 124: Antibody-Mediated Rejection, Lung - p. 395 144. Chapter 125: Acute Cellular Rejection, Grade A - p. 397 145. Chapter 126: Acute Cellular Rejection, Grade B - p. 399 146. Chapter 127: Chronic Allograft Dysfunction, Lung - p. 401 147. Noninfectious Lesions - p. 403 148. Chapter 128: Organizing Pneumonia - p. 403 149. Chapter 129: Microaspiration - p. 405 150. Infections - p. 407 151. Chapter 130: Bacterial Infections - p. 407 152. Chapter 131: Viral Infections - p. 409 153. Chapter 132: Fungal Infections, Lung - p. 413 154. Section 8: Intestinal Transplantation - p. 417 155. Chapter 133: Pathologic Classification of Intestinal Allograft Diseases - p. 417 156. Chapter 134: Indications and Evaluation of Explant - p. 421 157. Chapter 135: Reperfusion Injury - p. 425 158. Chapter 136: History of Intestinal and Multivisceral Transplantation - p. 429 159. Allograft Rejection/Immunological Injury - p. 431 160. Chapter 137: Acute Antibody-Mediated Rejection, Intestine - p. 431 161. Chapter 138: Acute Cellular Rejection, Intestine - p. 435 162. Chapter 139: Chronic Rejection, Intestine - p. 443 163. Chapter 140: Stomach Rejection - p. 447 164. Chapter 141: Colon Rejection - p. 451 165. Chapter 142: Graft-vs.-Host Disease, Intestine - p. 455 166. Infections - p. 459 167. Chapter 143: Bacterial and Fungal Infections - p. 459 168. Chapter 144: Adenovirus, Intestine - p. 463 169. Chapter 145: Rotavirus, Cytomegalovirus, and Herpes Simplex Virus - p. 467 170. Chapter 146: Epstein-Barr Virus, Intestine - p. 471 171. Section 9: Pancreas Transplantation - p. 477 172. Chapter 147: Pathologic Classification of Pancreas Allograft Diseases - p. 477 173. Chapter 148: Clinical Considerations in Pancreas Transplant Evaluation - p. 481 174. Chapter 149: History of Pancreas Transplantation - p. 487 175. Chapter 150: History of Islet Transplantation - p. 489 176. Surgical Complications - p. 491 177. Chapter 151: Surgical Aspects and Complications, Pancreas - p. 491 178. Allograft Rejection - p. 499 179. Chapter 152: T-Cell-Mediated Rejection, Pancreas - p. 499 180. Chapter 153: Antibody-Mediated Rejection, Pancreas - p. 505 181. Chapter 154: Pancreas Allograft Fibrosis/Graft Sclerosis - p. 509 182. Graft Dysfunction - p. 513 183. Chapter 155: Recurrent Diabetes Mellitus - p. 513 184. Chapter 156: Islet Cell Toxicity and Islet Amyloid Deposition - p. 517 185. Infections - p. 519 186. Chapter 157: Intraabdominal and Opportunistic Infections - p. 519 187. Section 10: Vascularized Composite Allotransplantation - p. 525 188. Chapter 158: History of Vascularized Composite Allotransplantation - p. 525 189. Chapter 159: Complications of Vascularized Composite Allotransplantation - p. 529 190. Allograft Rejection - p. 531 191. Chapter 160: Acute T-Cell- and Antibody-Mediated Rejection - p. 531 192. Chapter 161: Chronic Rejection - p. 539 193. Section 11: Posttransplant Neoplastic Disorders - p. 541 194. Chapter 162: Posttransplant Lymphoproliferative Diseases - p. 541 195. INDEX - p. 553
